6-K

FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

dated March 31, 2021

Commission File Number 1-15148

BRF S.A.
(Exact Name as Specified in its Charter)

N/A
(Translation of Registrant’s Name)

8501, Av. das Naçoes Unidas, 1st Floor
Pinheiros - 05425-070-São Paulo – SP, Brazil
(Address of principal executive offices) (Zip code)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x   Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1):                   

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7):                   

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o   No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.

*             *             *

This material includes certain forward-looking statements that are based principally on current expectations and on projections of future events and financial trends that currently affect or might affect the Company’s business, and are not guarantees of future performance.  These forward-looking statements are based on management’s expectations, which involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the Company’s control and any of which could cause actual financial condition and results of operations to differ materially fom those set out in the Company’s forward-looking statements.  You are cautioned not to put undue reliance on such forward-looking statements.  The Company undertakes no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statements.  The risks and uncertainties relating to the forward-looking statements in this Report on Form 6-K, including Exhibit 1 hereto, include those described under the captions “Forward-Looking Statements” and “Item 3. Key Information — D. Risk Factors” in the Company’s annual report on Form 20-F for the year ended December 31, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 31, 2021
	BRF S.A.
	By:	/s/ Carlos Alberto Bezerra de Moura
		Name:	Carlos Alberto Bezerra de Moura
		Title:	Chief Financial and Investor Relations Officer

EXHIBIT INDEX

Exhibit	Description of Exhibit
1	ANNOUNCEMENT TO THE MARKET

EX-99.1

BRF S.A.

PUBLICLY-HELD COMPANY
CNPJ 01.838.723/0001-27

NIRE 42.300.034.240

CVM 16269-2

ANNOUNCEMENT TO THE MARKET

BRF S.A. (“BRF” or “Company”) (B3: BRFS3; NYSE: BRFS) communicates to its shareholders and to the market in general that it has approved the donation of food, medical supplies, support to research and social development funds including logistics support, in an amount equal to R$50 million, approximately, in order to contribute with the efforts to combat the effects of the Covid-19 pandemic.

In Brazil, such action will reach hospitals, philanthropic entities, social assistance organizations and health professionals in the states and municipalities, additionally to the support for the federal health system. Such initiative contemplates 15 Brazilian states, where BRF has productive units, distribution centers, and corporate offices, including institutions that assist vulnerable populations, many of whom had their situation exacerbated by the pandemic, such as low-income families, seniors nursing homes, child and youth care centers, and families in general.

Furthermore, the Company plans to donate hospital supplies and medical equipment such as ventilators, oxygen and ICU beds that will supply municipal and state departments and health entities. Other social development actions are also foreseen, aiming to contribute with solutions in light of the challenges imposed by the aggravation of the pandemic.

As a global corporation, the Company will extend such initiative to countries where it has productive units, such as Turkey and the United Arab Emirates.

All donations will be evaluated and monitored by the Donations and Sponsorships Committee, in connection with the BRF Institute, in order to ensure an adequate process control, as the Company has been done so far.

Additionally, BRF maintains all efforts required to support productive activities and ensure supply, embracing new protocols and preventive measures to protect its employees and third parties.

Therefore, the Company reinforces its purpose, corporate citizenship and commitment with actions to minimize the impacts of the Covid-19 pandemic and will keep its shareholders and the market in general duly informed about any further additional initiatives regarding the present announcement.

São Paulo, March 31, 2021

Carlos Alberto Bezerra de Moura

Chief Financial and Investor Relations Officer

BRF S.A.